These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. SMS 201-995 and provocation tests in preparation of patients with carcinoids for surgery or hepatic arterial embolization. Ahlman H, Ahlund L, Dahlström A, Martner J, Stenqvist O, Tylén U. Anesth Analg; 1988 Dec; 67(12):1142-8. PubMed ID: 2461665 [Abstract] [Full Text] [Related]
10. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. Kvols LK, Moertel CG, O'Connell MJ, Schutt AJ, Rubin J, Hahn RG. N Engl J Med; 1986 Sep 11; 315(11):663-6. PubMed ID: 2427948 [Abstract] [Full Text] [Related]
11. [Treatment of carcinoid syndrome with a somatostatin analogue]. Döbrönte Z, Stöckert A, Végh G, Varga L. Orv Hetil; 1992 Mar 22; 133(12):731-4. PubMed ID: 1372969 [Abstract] [Full Text] [Related]
12. Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Norheim I, Oberg K, Theodorsson-Norheim E, Lindgren PG, Lundqvist G, Magnusson A, Wide L, Wilander E. Ann Surg; 1987 Aug 22; 206(2):115-25. PubMed ID: 2440390 [Abstract] [Full Text] [Related]
19. The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin. Ahlman H, Dahlström A, Grönstad K, Tisell LE, Oberg K, Zinner MJ, Jaffe BM. Ann Surg; 1985 Jan 22; 201(1):81-6. PubMed ID: 2578277 [Abstract] [Full Text] [Related]